跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Loracid - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Loracid
Approved
STANDARD
Loracid
Cadila Pharmaceuticals Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
27c65bb94c967310
Company
Cadila Pharmaceuticals Ltd.
Type
Standard
Approval Details
Approval Id
27c65bb94c967310
Drug Approval Philippines Name
Loracid
Product Name
Loracid
Registration Number
DRP-869-03
Brand Name
Loracid
Generic Name
Ranitidine (as Hydrochloride)
Dosage Form
Solution For Injection (IM/IV)
Dosage Strength
25 mg/mL
Manufacturer
Cadila Pharmaceuticals Ltd.
Importer
Ambica International Corporation
Distributor
D&G Pharma
Company Detail Path
/organization/cadila-pharmaceuticals-ltd
Issuance Date
31 October 2023
Expiry Date
12 March 2029
Pharmacologic Category
H2 Receptor Antagonist
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
27c65bb94c967310
Type
Standard
Back to Philippines FDA Approvals